close Icon

Research Articles

Explore our library of peer-reviewed publications below, with contributions from Burnet researchers.

See also: Research Reports + Policy Briefs

Form Loading Icon
'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.

Barratt MJ, Lenton S, Maddox A, Allen M

'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.
Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Tan HY, Yong YK, Shankar EM, Paukovics G, Ellegård R, Larsson M, Kamarulzaman A, French MA, Crowe SM

Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.

Chronister KJ, Lintzeris N, Jackson A, Ivan M, Dietze PM, Lenton S, Kearley J, van Beek I

Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.
IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection.

Torres D, Köhler A, Delbauve S, Caminschi I, Lahoud MH, Shortman K, Flamand V

IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection.
Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.

Toliman P, Badman SG, Gabuzzi J, Silim S, Forereme L, Kumbia A, Kombuk B, Kombati Z, Allan J, Munnull G, Ryan C, Vallely LM, Kelly-Hanku A, Wand H, Mola GDL, Guy R, Siba P, Kaldor JM, Tabrizi SN, Vallely AJ

Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.

Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME

Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.